MedTrace Logo

The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor

NCT04405557 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 757

Last updated 2025-09-04

No results posted yet for this study

Summary

This is a observational, multicenter study, monitoring the circulating tumor DNA (ctDNA) in people who is at risk of cancers，assessing the sensitivity and specificity of ctDNA detection in early screening of pan-carcinoma.

Conditions

  • Early Detection of Cancer

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER

  • Geneplus-Beijing Co. Ltd.

    lead INDUSTRY

Principal Investigators

  • Qiang Zeng, MD · Chinese PLA General Hospital

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-12
Primary Completion
2022-01-16
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405557 on ClinicalTrials.gov